Drug Trial Radar · NCT04603833
A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC
Last checked: Nov 19, 2026Latest source record: Feb 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Dec 2, 2020
Primary completion
Oct 1, 2022
Study completion Dec 31, 2022
Sponsor
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 27, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this trial is to evaluate SHR3680 combined with Docetaxel to improve Metastatic Castration Resistant Prostate Cancer Patients whether the patient's Time to prostate specific antigen (PSA) progression is superior to SHR3680 or Docetaxel single drug.
Conditions
- Prostate Cancer Metastatic
Interventions
SHR3680+DocetaxelDrug
Participants will receive SHR3680 combined with Docetaxel
SHR3680Drug
Participants will receive SHR3680
DocetaxelDrug
Participants will receive Docetaxel
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to prostate specific antigen (PSA) progressionTime frame: [Time Frame: Approximately 24 months]
- Adverse Event(AE)Time frame: [Time Frame: Approximately 24 months]
Locations
1 site in 1 country. Site status is shown where the registry gives one.
West China Hospital of Sichuan University
Chengdu, Sichuan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.